Cargando…
Drugs That Induce or Cause Deterioration of Myasthenia Gravis: An Update
Myasthenia gravis (MG) is an autoimmune neuromuscular disorder which is characterized by presence of antibodies against acetylcholine receptors (AChRs) or other proteins of the postsynaptic membrane resulting in damage to postsynaptic membrane, decreased number of AChRs or blocking of the receptors...
Autores principales: | Sheikh, Shuja, Alvi, Usman, Soliven, Betty, Rezania, Kourosh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8038781/ https://www.ncbi.nlm.nih.gov/pubmed/33917535 http://dx.doi.org/10.3390/jcm10071537 |
Ejemplares similares
-
Current Treatment of Myasthenia Gravis
por: Alhaidar, Mohammed K., et al.
Publicado: (2022) -
Myasthenia Gravis: Epidemiology, Pathophysiology and Clinical Manifestations
por: Dresser, Laura, et al.
Publicado: (2021) -
Update on ocular myasthenia gravis in Taiwan
por: Lin, Chao-Wen, et al.
Publicado: (2018) -
An update on treatments in myasthenia gravis
por: Jones, Lliwen A., et al.
Publicado: (2016) -
Myasthenia gravis
por: Juel, Vern C, et al.
Publicado: (2007)